Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C, Tramontana M, Patacchini R, Lecci A, Catalani C, Catalioto RM, Meini S, Valenti C, Altamura M, Giuliani S, Maggi CA. Cialdai C, et al. Among authors: meini s. Eur J Pharmacol. 2006 Nov 7;549(1-3):140-8. doi: 10.1016/j.ejphar.2006.08.021. Epub 2006 Aug 26. Eur J Pharmacol. 2006. PMID: 16979621
MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
Valenti C, Cialdai C, Giuliani S, Lecci A, Tramontana M, Meini S, Quartara L, Maggi CA. Valenti C, et al. Among authors: meini s. J Pharmacol Exp Ther. 2005 Nov;315(2):616-23. doi: 10.1124/jpet.105.088252. Epub 2005 Jul 18. J Pharmacol Exp Ther. 2005. PMID: 16027229
Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptor.
Fattori D, Porcelloni M, D'Andrea P, Catalioto RM, Ettorre A, Giuliani S, Marastoni E, Mauro S, Meini S, Rossi C, Altamura M, Maggi CA. Fattori D, et al. Among authors: meini s. J Med Chem. 2010 May 27;53(10):4148-65. doi: 10.1021/jm100176s. J Med Chem. 2010. PMID: 20408549
Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E₂ release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes.
Meini S, Cucchi P, Tinti L, Niccolini S, Bellucci F, Catalani C, Valenti C, Galeazzi M, Fioravanti A, Maggi CA. Meini S, et al. Naunyn Schmiedebergs Arch Pharmacol. 2012 Aug;385(8):777-86. doi: 10.1007/s00210-012-0762-y. Epub 2012 May 26. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 22638761
145 results